Review article: The medical treatment of Crohn's perianal fistulas
- PMID: 15113362
- DOI: 10.1111/j.1365-2036.2004.01917.x
Review article: The medical treatment of Crohn's perianal fistulas
Abstract
Perianal fistulas are a frequent manifestation of Crohn's disease. The correct application of the newer diagnostic and therapeutic agents for treating perianal Crohn's disease are beginning to be better defined. In general, a combined medical and surgical approach is preferred. The perianal disease process should first be fully delineated with endoscopy and either MRI or EUS before treatment is begun. Patients are then stratified into one of three groups: simple fistulas and no proctitis; simple fistulas and concomitant proctitis; and complex fistulas. Patients with simple fistulas and no proctitis can be treated medically with a combination of antibiotics and an immunosuppressive agent (azathioprine or mercaptopurine). Patients with simple fistulas and concomitant proctitis should have infliximab added to their treatment plan. Complex fistulas require surgical intervention first prior to medical treatment. A combination of antibiotics, immunosuppressive therapy and infliximab are then initiated to facilitate fistula healing.
Similar articles
-
Anti-TNF-alpha (infliximab) used as induction treatment in case of active proctitis in a multistep strategy followed by definitive surgery of complex anal fistulas in Crohn's disease: a preliminary report.Dis Colon Rectum. 2005 Apr;48(4):758-67. doi: 10.1007/s10350-004-0828-0. Dis Colon Rectum. 2005. PMID: 15750797 Clinical Trial.
-
Combining infliximab with 6-mercaptopurine/azathioprine for fistula therapy in Crohn's disease.Am J Gastroenterol. 2002 Aug;97(8):2022-5. doi: 10.1111/j.1572-0241.2002.05918.x. Am J Gastroenterol. 2002. PMID: 12190171
-
Review article: treatment of perianal fistulizing Crohn's disease.Aliment Pharmacol Ther. 2004 Oct;20 Suppl 4:106-10. doi: 10.1111/j.1365-2036.2004.02060.x. Aliment Pharmacol Ther. 2004. PMID: 15352905 Review.
-
Treatment of perianal fistulas in Crohn's disease by local injection of antibody to TNF-alpha accounts for a favourable clinical response in selected cases: a pilot study.Scand J Gastroenterol. 2006 Sep;41(9):1064-72. doi: 10.1080/00365520600609941. Scand J Gastroenterol. 2006. PMID: 16938720
-
Review article: medical, surgical and radiological management of perianal Crohn's fistulas.Aliment Pharmacol Ther. 2011 Jan;33(1):5-22. doi: 10.1111/j.1365-2036.2010.04486.x. Epub 2010 Oct 29. Aliment Pharmacol Ther. 2011. PMID: 21083581 Review.
Cited by
-
Where Are We and Where to Next?-The Future of Perianal Crohn's Disease Management.J Clin Med. 2023 Oct 6;12(19):6379. doi: 10.3390/jcm12196379. J Clin Med. 2023. PMID: 37835022 Free PMC article. Review.
-
Magnetic resonance imaging may predict deep remission in patients with perianal fistulizing Crohn's disease.World J Gastroenterol. 2017 Jun 21;23(23):4285-4292. doi: 10.3748/wjg.v23.i23.4285. World J Gastroenterol. 2017. PMID: 28694669 Free PMC article.
-
MRI characteristics of proctitis in Crohn's disease on perianal MRI.Abdom Radiol (NY). 2016 Oct;41(10):1918-30. doi: 10.1007/s00261-016-0802-z. Abdom Radiol (NY). 2016. PMID: 27315072 Free PMC article.
-
Surgical management of complex perianal fistula revisited in a systematic review: a critical view of available scientific evidence.BMC Surg. 2023 Feb 5;23(1):29. doi: 10.1186/s12893-023-01912-z. BMC Surg. 2023. PMID: 36740680 Free PMC article.
-
The impact of thiopurines on surgical outcomes in inflammatory bowel disease: do they make a difference?F1000Prime Rep. 2013 Nov 1;5:50. doi: 10.12703/P5-50. eCollection 2013. F1000Prime Rep. 2013. PMID: 24273651 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical